Calcium is not a routine drug in cardiac arrest. It’s given during a code only when the arrest has a specific reversible cause that calcium can fix: dangerously high potassium (hyperkalemia), very low calcium (hypocalcemia), or overdose on calcium channel blocker medications. Outside those scenarios, giving calcium during a code appears to offer no benefit and may worsen outcomes.
The Three Indications for Calcium in a Code
Current resuscitation guidelines reserve calcium for three situations during cardiac arrest. The first, and most common, is hyperkalemia. When potassium levels climb high enough to disrupt the heart’s electrical system, calcium counteracts those effects and can restore a viable rhythm. The second is hypocalcemia, where calcium levels have dropped low enough to impair cardiac function on their own. The third is calcium channel blocker overdose, where the drug that caused the arrest works by blocking the same channels that calcium flows through, so flooding the system with calcium helps overcome that blockade.
In all three cases, calcium targets the specific problem that triggered or is sustaining the arrest. It is not used as a general cardiac stimulant, and it does not replace epinephrine or other standard code medications.
How Calcium Works Against High Potassium
For decades, textbooks described calcium’s role in hyperkalemia as “membrane stabilization,” the idea being that it restores the normal electrical charge across heart cell membranes. Recent research has overturned that explanation. A study published in Critical Care Medicine found that calcium does not actually restore the resting membrane potential that high potassium disrupts. Instead, it works through a different pathway entirely.
When potassium is dangerously elevated, the heart’s normal sodium-based electrical conduction slows dramatically. This shows up on an ECG as a widening QRS complex, and it can deteriorate into a fatal rhythm. Calcium restores conduction by opening an alternative route: electrical signals propagate through calcium-dependent channels instead of the compromised sodium channels. In the study, calcium treatment improved conduction velocity by about 44%, narrowing the QRS complex and normalizing the ECG pattern. When researchers blocked calcium channels, this rescue effect disappeared, confirming that calcium-dependent conduction, not membrane stabilization, is the actual mechanism.
There may also be a secondary benefit. Higher calcium concentrations in the tiny spaces between heart muscle cells appear to enhance something called ephaptic coupling, essentially improving the ability of electrical signals to jump from one cell to the next even when normal conduction pathways are impaired.
How Calcium Helps in CCB Overdose
Calcium channel blockers work by preventing calcium from entering heart and blood vessel cells, which slows the heart rate and lowers blood pressure. In overdose, this effect becomes extreme: the heart can slow to the point of arrest, and blood pressure collapses. Giving calcium in large doses helps overwhelm the drug’s blockade by increasing the amount of calcium available to push through channels that aren’t fully blocked.
The typical approach is a bolus of 10 to 20 mL of 10% calcium chloride solution (or 30 mL of 10% calcium gluconate) infused over about five minutes. If the patient doesn’t respond, repeat doses can be given every 20 minutes. Because the effect of each dose is short-lived, lasting only minutes, a continuous infusion is sometimes needed to maintain the benefit.
Why Calcium Is Not Given Routinely
For arrests without one of those three specific causes, calcium not only fails to help but may cause harm. A randomized trial by Vallentin and colleagues was stopped early after a pre-planned interim analysis suggested the calcium group was doing worse. Among patients who received calcium, 3.6% survived with a favorable neurological outcome at 90 days, compared to 9.1% in the group that did not receive calcium. At one year, the gap persisted: 3.6% versus 8.6% survived with good neurological function. Quality-of-life scores were also lower in the calcium group at every time point measured, though the confidence intervals were wide.
Earlier observational studies had shown similar patterns, though those results were complicated by resuscitation time bias. Patients who receive more drugs during a code tend to be the ones who have been in arrest longer, so they naturally have worse outcomes regardless of what drugs they received. The randomized trial, which eliminated that bias, still pointed in the same direction.
The Risk of Calcium Overload
One reason routine calcium may be harmful relates to what happens at the cellular level during and after cardiac arrest. When the heart loses blood flow and then regains it (ischemia followed by reperfusion), calcium floods into the energy-producing compartments of heart cells, the mitochondria. This calcium overload, combined with a burst of oxidative stress during reperfusion, triggers the opening of a destructive pore in the mitochondrial membrane. Once that pore opens, the mitochondria swell, release their contents, and the cell dies. Adding extra calcium from an IV during this vulnerable window could accelerate that process in heart tissue already on the edge of survival.
Digoxin Toxicity: A Key Caution
One situation where calcium is specifically avoided during a code is suspected digoxin toxicity. Digoxin works by increasing calcium inside heart cells. If you then inject more calcium intravenously, the combined calcium load can theoretically push the heart into an irreversible state of contraction, sometimes called “stone heart,” where the muscle locks in place and cannot relax.
The evidence on this is genuinely mixed. One retrospective study of 159 patients with digoxin toxicity found no significant difference in mortality between those who received calcium and those who didn’t (22% versus 20%). Animal studies have also shown no clear mortality difference. But the theoretical mechanism is plausible, involving uncontrolled calcium binding to the contractile proteins inside heart cells, and case reports of stone heart after calcium administration in digoxin-toxic patients do exist. Given the uncertain risk and the availability of a specific antidote for digoxin toxicity, current practice favors avoiding calcium in these patients.
Calcium Chloride vs. Calcium Gluconate
Two formulations are available. Calcium chloride delivers roughly three times more elemental calcium per milliliter than calcium gluconate at the same concentration. This makes calcium chloride the preferred choice in a code, where speed matters and you want the maximum calcium effect per dose. Calcium gluconate was once thought to require liver metabolism before its calcium became available, but research in both children and animals has shown that it ionizes rapidly on its own, and when given at equivalent elemental calcium doses (a 3:1 volume ratio), both formulations produce the same rise in blood calcium levels and the same cardiovascular effects.
The practical difference comes down to access. Calcium chloride is a vesicant with an osmolarity of about 2,040 mOsm/L, meaning if it leaks out of the vein during infusion, it can cause severe tissue damage ranging from skin blistering to deep necrosis that extends into muscle and fascia. The preferred route is through a central line or a deep vein. In a code, when central access isn’t available, peripheral administration is considered acceptable using the largest bore catheter in the most proximal vein possible, but it carries real risk if extravasation occurs. Calcium gluconate is less caustic and somewhat safer through a peripheral line, which is why some institutions prefer it outside of full cardiac arrest.